Figure S1. Extracellular and intracellular metabolites of commercially available and patient derived GBM cells and NHAs AB C NHA GBM NHA GBM PCA plot of.

Slides:



Advertisements
Similar presentations
Concerns and Possible Solutions From Harms  If metabolites are cycled by a single organism, or within a community of organisms, how can we reproducibly.
Advertisements

© 2008 Applera Corporation and MDS Inc. MultiQuant ™ Software © 2008 Applera Corporation and MDS Inc.
Place, date, unit, occasion etc. Slide 1 Nikoline Juul Nielsen, Post Doc Soil and Environmental Chemistry (present) Bioorganic Chemistry (previous) Exploratory.
* CORRESPONDING AUTHOR Glucagon Bioanalysis by LC-MS: “Unprecedented Level of Sensitivity (10pg/mL) for a Novel Formulation” Jean-Nicholas Mess 1, Louis-Philippe.
June 9th, 2013 Matthew J. Rardin June 9th, 2013 Matthew J. Rardin MS1 and MS2 crosstalk in label free quantitation of mass spectrometry data independent.
Low lightHigh light High light response in Arabidopsis thaliana 4 days 1100 transcripts change Anthocyanin light response mutant.
Metabolomics MS and Data Analysis PCB 5530 Tom Niehaus Fall 2015.
Target Analyses in Parallel Reaction Monitoring Mode (PRM)
Agenda Welcome from the Skyline team!
H M Arif Ullah, Hye Jin Chung*
Metabolomics Part 2 Mass Spectrometry
Metabolomics Data Analysis
A B C Figure S1. LC-MS and LC-MS/MS data on [M+H]+ ion with 837 m/z formed when MDI is reacted with oxidized glutathione. Following reactivity of MDI with.
Tandem MS.
Supplemental figures. Observed extracted ion chromatograms (XICs) of each of the ten peptides from five standard proteins using dual ion funnel and standard.
Multiple Reaction Monitoring (MRM) Selected Reaction Monitoring (SRM)
N-Linolenoyl-L-glutamine: 1H-NMR (CD3OD) δ: (m, 6H), 4
Figure 1. MS<sup>E</sup> data of THC-COOH
Agenda Welcome from the Skyline team!
From: IGF-1 Regulates the Extracellular Level of Active MMP-2 and Promotes Müller Glial Cell Motility Invest. Ophthalmol. Vis. Sci ;56(11):
Pinpointing phosphorylation sites using Selected Reaction Monitoring and Skyline Christina Ludwig group of Ruedi Aebersold, ETH Zürich.
Control of Metabolic Pathways (2)
Volume 15, Issue 6, Pages (June 2008)
Volume 129, Issue 2, Pages (August 2005)
Spectra of ESI–MS of 100 μM solution of catechol in H2O at pH 8
Phosphopeptide sequencing by MALDI-TOF/TOF of the C-terminal tail of AtPIP2;1.A, MS/MS spectrum of singly phosphorylated 277SLGSFRSAANV287 (m/z ).
Volume 21, Issue 7, Pages (July 2014)
Volume 132, Issue 1, Pages (January 2007)
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M6
Jesse C. Seegmiller, John H. Eckfeldt, John C. Lieske 
Phosphopeptide sequencing by MALDI-TOF/TOF of the C-terminal tail of AtPIP2;4.A, MS/MS spectrum of singly phosphorylated 277ALGSFGSFGSFRSFA291 (m/z ).
Volume 144, Issue 4, Pages (April 2013)
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M2 M2'
Supplemental Figure. Passing & Bablok regression graphs for each 25(OH)D assay compared with ID-XLC-MS/MS in each clinical subject group. R is shown in.
Proteomics Informatics David Fenyő
by Jesmond Dalli, and Charles N. Serhan
Phosphopeptide sequencing by MALDI-TOF/TOF of the C-terminal tail of AtPIP2;7.A, MS/MS spectrum of singly phosphorylated 270ALGSFRSNATN280 (m/z ).
Proteomic Approaches to Cancer Biomarkers
(A) (E) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M4 M4'
(E) (A) (B) (C) (F) (D) Control HLM MLM Chemical synthesis M3'' M3'''
Volume 24, Issue 5, Pages (November 2016)
Discrimination and Quantification of True Biological Signals in Metabolomics Analysis Based on Liquid Chromatography-Mass Spectrometry  Lixin Duan, István.
Treating the Periphery to Ameliorate Neurodegenerative Diseases
Volume 24, Issue 10, Pages e7 (October 2017)
Volume 6, Issue 3, Pages (March 1997)
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3- Dioxygenase and Bystander M2 Macrophage Differentiation  Moïra François, Raphaëlle.
MIDAS workflow (MRM-triggered MS/MS) verification of the identity of peptide DLQFVEVTDVK representing fibronectin (normal concentration, ∼300 μg/ml)
A Metabolomic View of Staphylococcus aureus and Its Ser/Thr Kinase and Phosphatase Deletion Mutants: Involvement in Cell Wall Biosynthesis  Manuel Liebeke,
Relative quantitation of phosphopeptides from conditioned media from subtype specific breast cancer cell lines. Relative quantitation of phosphopeptides.
Representative example of LAXIC performance for complex plant phosphoproteome. Representative example of LAXIC performance for complex plant phosphoproteome.A.
MS/MS spectra of INEILSNALKR with a Lys residue modified with SUMO1 or SUMO3 remnant chains. MS/MS spectra of INEILSNALKR with a Lys residue modified with.
Altered pathways in prostate cancer.
2D-LC-MS/MS analysis of tryptic digest of HEK293-SUMO3 cells (2 μg inj
Example of MS/MS spectrum of peptide FPTLTGFNR (hypothetical protein with signal peptide EAK88888; N77) from a protein digestion mixture prepared by labeling.
Significant alterations in cysteine and methionine metabolism.
Volume 17, Issue 4, Pages (April 2010)
Comparisons of MS/MS ion fragmentation spectra derived from GNPS network annotations (see Table S4 posted at ftp://massive.ucsd.edu/MSV /updates/ _aedlund_ /other/)
Chromatograms, MS and MS/MS spectra obtained by LC-MS/MS (Q-TOF) of peptides from UPIII identified after Western blotting followed by on-membrane digestion.
Identification and quantification of cathepsin D in chronic pancreatitis.A, identification of two peptides, AIGAVPLIQGEYMIPCEK (A) and LLDIACWIHH (MS/MS.
One Enzyme, Three Metabolites: Shewanella algae Controls Siderophore Production via the Cellular Substrate Pool  Sina Rütschlin, Sandra Gunesch, Thomas.
Volume 17, Issue 8, Pages (August 2010)
PIP3 (38:4) pmol/mg (tissue)
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Metabolomics study of esophageal adenocarcinoma
The new kid on the block(ade) of the IGF-1 receptor
Fig. 1 Cancer cell lines exhibiting homozygous deletion of MTAP show altered patterns of metabolite levels. Cancer cell lines exhibiting homozygous deletion.
Figure 4. EC-18 dephosphorylated activated STAT6
Scatter plot of serum OPN levels and its correlation with patient survival. Scatter plot of serum OPN levels and its correlation with patient survival.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
Validation of NAA's cancer specificity in lung cancer.
Presentation transcript:

Figure S1. Extracellular and intracellular metabolites of commercially available and patient derived GBM cells and NHAs AB C NHA GBM NHA GBM PCA plot of Intracellular Metabolites PCA Plot of Extracellular Metabolites D

Figure S2. Total and extracted ion chromatograms of intracellular metabolites GBMNHA Total Ion Chromatogram Methionine Kynurenine Tryptophan 5-methylthioadenosine Extracted Ion Chromatogram Counts Acquisition Time (min)

Total Ion Chromatogram Extracted Ion Chromatogram GBMNHA Kynurenine 5-methylthioadenosine Counts Acquisition Time (min) Figure S3. Total and extracted ion chromatograms of extracellular metabolites

GBM Synthetic [M+H] + Counts Mass-to-Charge (m/z) Figure S4. Targeted analysis MS/MS product ion spectrum of methionine

GBM Synthetic Counts Mass-to-Charge (m/z) [M+H] + Figure S5. Targeted analysis MS/MS product ion spectrum of tryptophan

Figure S6. Targeted analysis MS/MS product ion spectrum of kynurenine GBM Synthetic [M+H] + Counts Mass-to-Charge (m/z)

GBM Synthetic Counts Mass-to-Charge (m/z) [M+H] + Figure S7. Targeted analysis MS/MS product ion spectrum of MTA

Figure S8. Total ion chromatogram and multiple reaction monitoring of different concentrations of methionine y= *x R^2 = Concentration (ng/ml) Responses Acquisition Time (min) Relative Intensity Mass-to-Charge (m/z) Counts A B C

Figure S9. Total ion chromatogram and multiple reaction monitoring of different concentrations of kynurenine Relative Intensity Acquisition time (minutes) 1000 ng 500 ng 250 ng 125 ng 63 ng 32 ng Mass-to-Charge (m/z) Counts Concentration (ng/ml) Responses AB C

Figure S10. Key metabolites in methionine pathway

Figure S11. Calibration Curve and Multiple Reaction Monitoring of SAM and SAH A C B D y= *x – R^2 = y= *x – R^2 = Concentration (ng/ml) Responses Counts Mass-to-Charge (m/z)

Figure S12. Key metabolites in tryptophan pathway Normal cells Cancer cells KMO / KYNU triggers immune surveillance MDNSC 20 OSU 35 OSU 38 OSU 34 OSU 53 OSU 96 LN18 LN229 U118 OSU 61 OSU 68 TDO2 IDO  -Actin U87 MDNSC 20 OSU 35 OSU 38 OSU 34 OSU 53 OSU 96 LN18 LN229 U118 OSU 61 OSU 68 KMO  -Actin A B

Figures U87 U118 OSU96 OSU53 OSU61OSU68 Figure S13. Insilico analysis – Connecting metabolome and proteome in GBM cells

* * * * * ** * * Figure S14. Densitometric quantification of the chemiluminescence signals